ResearcherTongji UniversityActive in the last 2 years

Shengbo Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7497-2935; OpenAlex author ID A5040092895. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 2 papers

Papers 2

Targeting Splenic Myeloid Cells with Nanobiologics to Prevent Postablative Pancreatic Cancer Recurrence via Inducing Antitumor Peripheral Trained Immunity. Co-author DOI 10.1002/advs.202413562 ↗
Targeting tumor-associated CCR2+ macrophages to inhibit pancreatic cancer recurrence following irreversible electroporation. Co-author DOI 10.1126/sciadv.adw2937 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenwen Yue · 2 shared papers, 2025 · strength 0.42
- Paper Targeting Splenic Myeloid Cells with Nanobiologics to Prevent Postablative Pancreatic Cancer Recurrence via Inducing An… DOI 10.1002/advs.202413562 ↗
- Paper Targeting tumor-associated CCR2+ macrophages to inhibit pancreatic cancer recurrence following irreversible electropora… DOI 10.1126/sciadv.adw2937 ↗
Weichen Xu · 1 shared paper, 2025 · strength 0.20
- Paper Targeting tumor-associated CCR2+ macrophages to inhibit pancreatic cancer recurrence following irreversible electropora… DOI 10.1126/sciadv.adw2937 ↗
Weiwei Ren · 1 shared paper, 2025 · strength 0.20
- Paper Targeting tumor-associated CCR2+ macrophages to inhibit pancreatic cancer recurrence following irreversible electropora… DOI 10.1126/sciadv.adw2937 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.